I’ve been keeping an eye on Crawford & Company (NYSE:CRD.B) because I’m attracted to its fundamentals. Looking at the company as a whole, as a potential stock investment, I believe CRD.B has a lot to offer. Basically, it is a well-regarded dividend-paying company that has been able to sustain great financial health over the past. Below is a brief commentary on these key aspects. For those interested in understanding where the figures come from and want to see the analysis, read the full report on Crawford here.
Adequate balance sheet average dividend payer
CRD.B’s strong financial health means that all of its upcoming liability payments are able to be met by its current cash and short-term investment holdings. This implies that CRD.B manages its cash and cost levels well, which is a key determinant of the company’s health. CRD.B’s has produced operating cash levels of 0.2x total debt over the past year, which implies that CRD.B’s management has put its borrowings into good use by generating enough cash to cover a sufficient portion of borrowings.
CRD.B pays a decent dividend yield to its shareholders, exceeding the low-risk savings rate, which is what investors expect when they take on the risk of investing in the stock market.
For Crawford, I’ve put together three key aspects you should further examine:
- Future Outlook: What are well-informed industry analysts predicting for CRD.B’s future growth? Take a look at our free research report of analyst consensus for CRD.B’s outlook.
- Historical Performance: What has CRD.B’s returns been like over the past? Go into more detail in the past track record analysis and take a look at the free visual representations of our analysis for more clarity.
- Other Attractive Alternatives : Are there other well-rounded stocks you could be holding instead of CRD.B? Explore our interactive list of stocks with large potential to get an idea of what else is out there you may be missing!
To help readers see past the short term volatility of the financial market, we aim to bring you a long-term focused research analysis purely driven by fundamental data. Note that our analysis does not factor in the latest price-sensitive company announcements.
The author is an independent contributor and at the time of publication had no position in the stocks mentioned. For errors that warrant correction please contact the editor at email@example.com.